BiotechTube
Home/Aquilus Pharmaceuticals/Irving Sucholeiki, Ph.D.
IS

Irving Sucholeiki, Ph.D.

President & Chief Executive Officer

Aquilus Pharmaceuticals

Therapeutic Areas

Amyotrophic Lateral Sclerosis (ALS)Neurodegenerative Diseases

Aquilus Pharmaceuticals Pipeline

DrugIndicationPhase
AQU-118Amyotrophic Lateral Sclerosis (ALS)Phase 1

Leadership Team at Aquilus Pharmaceuticals

DJ
Darrell J. Nix, Ph.D.
Vice President, R&D
RS
Roy Sucholeiki, M.D.
CMO & Vice President, Clinical Development
View full Aquilus Pharmaceuticals profile